Cellebrite price target raised to $30 from $25 at TD Cowen
TD Cowen analyst Shaul Eyal raised the firm’s price target on Cellebrite (CLBT) to $30 from $25 and keeps a Buy rating on the shares. The firm ...
TD Cowen Reaffirms Their Buy Rating on DraftKings (DKNG)
TD Cowen analyst Lance Vitanza maintained a Buy rating on DraftKings (DKNG – Research Report) today and set a price target of $51.00. The ...
Equinix forecasts quarterly, annual revenue below estimates as strong dollar weighs
Equinix expects first-quarter revenue to be between $2.19 billion and $2.23 billion, below analysts' average estimate of ...
CRISPR upgraded to hold by TD Cowen on limited downside
TD Cowen has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to hold from sell, stating it now sees less downside to the stock. "We believe Casgevy expectations have bottomed out in the near term and ...
VCCircle4d
Carlyle's Quarterly Profit Misses Estimates As Private Equity Business Weighs
Carlyle Group's distributable fourth-quarter earnings missed market expectations on Tuesday, eclipsing a strong ...
TD Cowen raises McDonald's stock target to $305, keeps Hold rating
TD Cowen adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, raising the price target from $300.00 to $305.00.
The TRADE4d
From Cowen’s growth to TD’s vision: A new chapter in European equity trading
The TRADE sits down with TD Securities’ Carl Hayes, head of European cash equities, and James Baugh, managing director and ...
NBC Los Angeles6d
S&P 500 closes higher, Nasdaq pops nearly 1% Monday as investors shrug off tariff worries: Live updates
Stocks rose as traders appeared to shake off the latest tariff threat from President Donald Trump while they awaited key ...